Posted: Sunday, April 25, 2021. 8:33 am CST.
By Zoila Palma: The European Medicines Agency (EMA) said that a new review of the AstraZeneca COVID-19 vaccines indicated that its benefits increase with age and still outweigh risks despite recent links to blood clots.
The EMA issued a statement saying that its findings shows that the benefits of the vaccine increase with older people and infection rates.
“The benefits of Vaxzevria outweigh its risks in adults of all age groups; however, very rare cases of blood clots with low blood platelets have occurred following vaccination,” the statement said.
In addition, the agency said that the rare blood clots occurred in 1 in 100,000 people who received the vaccine.
“The most common side effects are usually mild or moderate and get better within a few days,” the agency added.
In early April, the same agency said that a rare but fatal form of blood clot affecting the brain should be listed as a side effect.
Channel News Asia reports that so far, 287 cases worldwide are linked to AstraZeneca, 25 to the Pfizer-BioNTech vaccine, eight to the Johnson and Johnson shot and five to the Moderna jab.
Аdvеrtіѕе wіth thе most visited news site in Веlіzе ~ Wе оffеr fullу сuѕtоmіzаblе аnd flехіblе dіgіtаl mаrkеtіng расkаgеѕ. Yоur соntеnt іѕ dеlіvеrеd іnѕtаntlу tо thоuѕаndѕ оf uѕеrѕ іn Веlіzе аnd аbrоаd! Соntасt uѕ аt email@example.com оr саll uѕ аt 501-601-0315.
© 2021, BreakingBelizeNews.com. This article is the copyrighted property of Breaking Belize News. Written permission must be obtained before reprint in online or print media. REPRINTING CONTENT WITHOUT PERMISSION AND/OR PAYMENT IS THEFT AND PUNISHABLE BY LAW.